News About: Goverment
KFDA approves 26 Stillen generics
Dong-A Pharm’s Stillen, is unlikely to become a cash cow product as a total of 26 drug manufacturers, including Chong Kung Dang Pharmaceutical, Dongwha Pharm and Kwagdong, obtained a nod for Stillen generics from the ...
Health ministry urged to lead R&D projects
Pharmaceutical analysts are voicing hopes about the health ministry’s plan to boost the domestic development of new drugs, as part of follow-up measures to the free trade agreement (FTA) signed with the United States....
Cabinet approves tax cut on entertainment expenses
The Lee Myung-bak administration approved during a Cabinet meeting on January 29 a measure to expand the scope of entertainment expenses.
Under the plan, enterprises will benefit from tax cut on wedding or funeral ...
Sunset provision set to apply to health and medical regulations
A presidential advisory panel on January 29 announced plans to expand the "sunset" rule to all domestic statutes, orders and programs, including medical and pharmaceutical matters to boost efficiency and government ac...
Government supports drug development to counter FTA
The government plans to increase its spending on the development of new drugs, as part of follow-up measures to the free trade agreement (FTA) signed with the United States.
The Ministry of Health, Welfare and Fam...
KFDA moves to monitor safety of marketed drugs
The Korea Food and Drug Administration said it has been implementing its on-spot inspection on marketed drugs to ensure the ongoing safety of marketed medicines.
The health watchdog said that it will look into the ...
Announcement to re-assess economic effectiveness of medicines provokes protest
The government’s announcement to consider some pacts of the planned re-assessment of insurance-covered medicines over their economic effectiveness has provoked criticism from the labor unions of the National Health In...
Government to push up with re-assessment plan over 3,000 drugs
The government has reaffirmed that it will re-evaluate the economic effectiveness of 3,000 medicines listed in national health insurance this year without any modification, rejecting the speculation that the re-assess...
Re-assessment of drugs’ economic effectiveness should be reserved, KPMA says
The government will have to delay its re-assessment plan over 3,000 medicines this year in the midst of business downturn, the Korea Pharmaceutical Manufacturers Association said in a statement.
In the statement co...
KFDA to attain judicial binding power
The Korea Food and Drug Administration plans to launch its own squad with both investigation and indictment rights, according to pharmaceutical sources.
The KFDA squad would crack down on those distributing or trad...
